C4orf51

Model summary

A soluble nuclear adaptor that is transcriptionally induced by a viral transactivator and operates in the nucleoplasm to organize higher-order assemblies. It likely functions by using a compact interaction module to scaffold and stabilize nuclear protein complexes, thereby tuning gene expression and RNA-processing pathways. Its activity is centered on assembling macromolecular assemblies rather than catalysis, and it is frequently co-expressed with a partner that is elevated in head and neck squamous cell carcinoma.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture: the sequence is entirely encompassed by IPR031708 (Protein of unknown function DUF4722 family) spanning residues 1–168.

   A single, full-length DUF family signature without additional catalytic or transmembrane modules indicates a soluble, non-enzymatic scaffold/adaptor. Such architectures typically mediate selective macromolecular assembly through multivalent surfaces rather than catalysis. This composition causally supports a binding-centric molecular role, aligning with GO:0005515 protein binding as the primary molecular function.

2. 02

   A binding-driven scaffold naturally feeds into higher-order assembly pathways.

   The explicit linkage to GO:0065003 protein-containing complex assembly is mechanistically consistent with a DUF4722-centered adaptor that nucleates or stabilizes nuclear protein complexes. The absence of enzymatic motifs and the presence of a single interaction-focused domain argue that the protein’s contribution to biology is executed by organizing assemblies rather than by direct chemical transformation.

3. 03

   Cellular localization follows from function and architecture.

   A soluble adaptor that organizes nuclear complexes is expected to reside in the nuclear interior rather than membranes or cytoskeleton. The experimentally supported nuclear residence and the formal cellular component GO:0005654 nucleoplasm together define the operational compartment. A nucleoplasmic scaffold can coordinate chromatin-associated and RNA-processing assemblies, which coheres with a role in complex assembly.

4. 04

   The reported phenotype—induction by a viral transactivator and association with a cellular partner that is up-regulated in head and neck squamous cell carcinoma—implies that this adaptor is mobilized in transcriptional or RNA-processing contexts that are frequently hijacked by viral programs and frequently intersect with nucleoplasmic assemblies relevant to epithelial malignancy.

   This contextualization strengthens the inference that the protein’s core activity is to assemble and stabilize nuclear complexes that regulate gene expression or RNA maturation.

5. 05

   Mechanistically, I hypothesize that the DUF4722 fold provides a compact interaction hub that recruits nucleoplasmic factors to build transient assemblies.

   Likely partners include nuclear scaffolds and RNA biogenesis modules; candidate interactors include nuclear body constituents (e.g., PML/TRIM19), transcriptional coactivators, and spliceosome-associated proteins. Through these interactions, the protein would modulate the composition and stability of nuclear complexes that govern transcriptional output and RNA handling, explaining both its assembly-centric function and its nuclear residency.